Capital expenditure · 2017–2025

Ideaya Biosciences capital expenditure

$2.4M−38.6% · FY2025

Ideaya Biosciences (IDYA) reported $2.4M in capital expenditure for fiscal 2025, −38.6% year on year.

$1.8M2017$1.7M2018$1.4M2019$493,0002020$2.6M2021$3.4M2022$2.4M2023$3.9M2024$2.4M2025
Ideaya Biosciences — Capital expenditure, 2017–2025
Fiscal yearCapital expenditureChangeFiling
FY20252025-12-31$2.4M−38.6%Open →
FY20242024-12-31$3.9M+62.9%Open →
FY20232023-12-31$2.4M−31.2%Open →
FY20222022-12-31$3.4M+30.2%Open →
FY20212021-12-31$2.6M+436.3%Open →
FY20202020-12-31$493,000−63.6%Open →
FY20192019-12-31$1.4M−20.8%Open →
FY20182018-12-31$1.7M−2.8%Open →
FY20172017-12-31$1.8M—Open →

Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +3.8%

Capital expenditure at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ideaya Biosciences capital expenditure |url=https://companiesranked.com/en/company/ideaya-biosciences/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ideaya Biosciences capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/ideaya-biosciences/capital-expenditure

BibTeX

@misc{companiesranked-en-company-ideaya-biosciences-capital-expenditure-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ideaya Biosciences capital expenditure}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ideaya-biosciences/capital-expenditure}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001193125-26-054533 · February 17, 2026

{{cite web |title=Ideaya Biosciences capital expenditure — 10-K (0001193125-26-054533) |url=https://www.sec.gov/Archives/edgar/data/1676725/000119312526054533/idya-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ideaya Biosciences overview